IRAPe, Irisin and IL-34 in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 19, 2019

Primary Completion Date

June 30, 2019

Study Completion Date

July 20, 2019

Conditions
Type2 Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

Blood sample

Ten ml of venous blood was collected from all participants in the early morning after an overnight 12 hour fast by venipuncture of the antecubital vein into sterile tubes. Plasma and sera were separated immediately and were stored at -70 C until biochemical analyses.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER

NCT04107259 - IRAPe, Irisin and IL-34 in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter